BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 26, 2022; 10(6): 1876-1882
Published online Feb 26, 2022. doi: 10.12998/wjcc.v10.i6.1876
Transileocolic endovascular treatment by a hybrid approach for severe acute portal vein thrombosis with bowel necrosis: Two case reports
Shin-ichiro Kumita, Hiromitsu Hayashi, Shoji Yokobori, Hiroshi Yoshida, Shiei Kim, Hiroyasu Furuki, Hidemasa Saito, Daisuke Yasui, Fumie Sugihara, Tatsuo Ueda, Sayaka Shirai
Sayaka Shirai, Tatsuo Ueda, Fumie Sugihara, Hidemasa Saito, Hiromitsu Hayashi, Shin-ichiro Kumita, Department of Radiology, Nippon Medical School Hospital, Bunkyo-ku 113-8603, Tokyo, Japan
Daisuke Yasui, Department of Radiology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki-shi 211-8533, Kanagawa, Japan
Hiroyasu Furuki, Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Tamanagayama Hospital, Tama-shi 206-8512, Tokyo, Japan
Shiei Kim, Shoji Yokobori, Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital, Bunkyo-ku 113-8603, Tokyo, Japan
Hiroshi Yoshida, Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital, Bunkyo-ku 113-8603, Tokyo, Japan
Author contributions: Shirai S, Ueda T, Sugihara F, Yasui D, Saito H, Furuki H, Kim S, and Yoshida H performed treatment and drafted the manuscript; Yokobori S, Hayashi H, and Kumita SI drafted the manuscript.
Informed consent statement: The patients gave their written informed consent for the publication of this case report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Tatsuo Ueda, MD, PhD, Senior Lecturer, Department of Radiology, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo, Bunkyo-ku 113-8603, Tokyo, Japan. s9015@nms.ac.jp
Received: July 5, 2021
Peer-review started: July 5, 2021
First decision: October 11, 2021
Revised: October 22, 2021
Accepted: January 19, 2022
Article in press: January 19, 2022
Published online: February 26, 2022
Processing time: 233 Days and 11.8 Hours
Abstract
BACKGROUND

Acute portal vein thrombosis (PVT) with bowel necrosis is a fatal condition with a 50%-75% mortality rate. This report describes the successful endovascular treatment (EVT) of two patients with severe PVT.

CASE SUMMARY

The first patient was a 22-year-old man who presented with abdominal pain lasting 3 d. The second patient was a 48-year-old man who presented with acute abdominal pain. Following contrast-enhanced computed tomography, both patients were diagnosed with massive PVT extending to the splenic and superior mesenteric veins. Hybrid treatment (simultaneous necrotic bowel resection and EVT) was performed in a hybrid operating room (OR). EVTs, including aspiration thrombectomy, catheter-directed thrombolysis (CDT), and continuous CDT, were performed via the ileocolic vein under laparotomy. The portal veins were patent 4 and 6 mo posttreatment in the 22-year-old and 48-year-old patients, respectively.

CONCLUSION

Hybrid necrotic bowel resection and transileocolic EVT performed in a hybrid OR is effective and safe.

Keywords: Bowel necrosis; Endovascular treatment; Hybrid operating room; Hybrid treatment; Portal vein thrombosis; Transileocolic approach; Case report

Core Tip: Acute portal vein thrombosis (PVT) with bowel necrosis is a fatal condition with no definite cure. This report describes successful endovascular treatment (EVT) in two severe PVT cases. Hybrid treatment (simultaneous necrotic bowel resection and EVT) was performed in a hybrid operating room. EVTs, including aspiration thrombectomy, catheter-directed thrombolysis (CDT), and continuous CDT, were performed via the ileocolic vein under laparotomy. By performing this procedure, we were able to achieve a good result for a disease with a low survival rate and did so with minimal intestinal resection.